logo-loader
viewMarrone Bio Innovations

Marrone Bio's biology-based seed treatments in Europe improved yields, cost effectively controlled soil insects

It showed significant benefits when its Foramin nutrient technology is used in conjunction with conventional or biology-based seed treatments

Marrone Bio Innovations - Marrone Bio Innovations Inc’s biology-based seed treatments in Europe demonstrated improved yields and cost-effective control of soil insects
Marrone Bio, based in Davis, California, provides bio-based pest management and plant health products for the US and international agricultural markets

Marrone Bio Innovations Inc (NASDAQ:MBII) announced Monday that its field trial results for biology-based seed treatments in Europe demonstrated improved yields and cost-effective control of soil insects and nematodes that are equivalent to or better than current industry standards. 

Additionally, the company said its wholly-owned subsidiary, Pro Farm Technology OY (Pro Farm), has demonstrated significant benefits to growers when its patented Foramin nutrient technology is used in conjunction with conventional or biology-based seed treatments. 

Foramin offers growers enhanced plant physiology, reduced plant stress, and improved yields and crop quality. 

READ: Marrone Bio's founder Dr Pamela Marrone to step down as CEO

Results from recent yield and stress tolerance trials will be presented by Kalle Virta, director of research and development for Pro Farm, at the “Exceed The Seed” event during the American Seed Trade Association meeting on Monday in Chicago.

“The past growing season marked our first international tests — including in the European Union — of the Marrone Bio suite of seed- and soil-applied products,” said Chief Commercial Officer Kevin Hammill. “These bioprotection products complement Pro Farm’s existing portfolio of plant health products. With Pro Farm’s broad international distribution capabilities, we expect to bring to more growers the benefits of MBI’s technology and broad bioprotection product portfolio.”

Marrone Bio’s and Pro Farm’s family of seed and soil treatment products are currently available to growers through its distribution and seed company partners in the US, Canada, Uruguay and Europe with near-term expansion into India, Australia, Brazil, Argentina, Paraguay, Bolivia and CIS (Commonwealth of Independent States) region for use in a wide variety of crops including corn, soybean, cotton, wheat, barley, sunflower, oilseed rape and vegetables.

MBI European Seed Treatment Field Trial Results

Corn seed treatment trials testing MBI-203 and MBI-206 for corn root worm and nematode control showed yield gains against both the untreated control and a currently used chemical option. When compared with the current treatment, yield gains as high as 35% were observed when used at commercial application rates.

Pro Farm Stress-Tolerance Greenhouse and Field Trial Results

Pro Farm tested its Foramin products for 18 different stress parameters across multiple growth stages for barley and wheat in both greenhouse and field conditions in Europe throughout 2019. Foramin is designed to be used in combination with a standard conventional seed treatment package. The Foramin products include both a seed treatment and a foliar-applied product.

Meanwhile, Marrone Bio also said last season’s results from barley and wheat field trials in Latin America showed yield increases in barley ranging from 2.1% to 6.7%; and in wheat from 9% to 14.3%. At current commodity prices, these yield gains would add approximately $8 to $26 per acre in revenue for barley growers, and approximately $44 to $68 per acre in revenue for wheat growers.

Marrone Bio, based in Davis, California, provides bio-based pest management and plant health products for the US and international agricultural and water markets. Boasting a portfolio of over 400 current and pending patents, the company’s products include Regalia, Stargus, Grandevo, Venerate, Majestene, Haven and Jet Oxide; in addition to these offerings, the company is also formulating another bioherbicide and biofumigant.

The company’s stock recently traded up more than 7% to $1.28 a share in New York. 

--ADDS share price--

Contact the author: [email protected]

Follow him on Twitter @PatrickMGraham

Quick facts: Marrone Bio Innovations

Price: 1.24 USD

NASDAQ:MBII
Market: NASDAQ
Market Cap: $172.74 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Marrone Bio Innovations named herein, including the promotion by the Company of Marrone Bio Innovations in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Marrone Bio Innovations receives approval from EPA for...

Marrone Bio Innovations (NASDAQ: MBII) CEO and Founder Dr Pam Marrone joined Steve Darling from Proactive Vancouver on Skype with news that two of its biofungicide products Stargus and Regalia have been approved by the U.S. Environmental Protection Agency for indoor and outdoor use on hemp...

on 01/07/2020

3 min read